Overview of stem cells and imaging modalities for cardiovascular diseases

Journal of Nuclear Cardiology

Volumn 13, Issue 4, 2006, Pages 554-569

  Chang, Gwendolen Y ^a   Xie, Xiaoyan ^a   Wu, Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 (4 FLUORO 3 [HYDROXYMETHYL]BUYL)GUANINE F 18; ABCIXIMAB; AMIODARONE; COPPER 64; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; INDIUM 111; IODINE 124; LUCIFERASE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; METHYLGLYOXAL BIS(4 METHYLTHIOSEMICARBAZONE); QUANTUM DOT; RED FLUORESCENT PROTEIN; TECHNETIUM 99M; TETROFOSMIN TC 99M; THALLIUM 201; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CARDIOLOGY; CARDIOVASCULAR DISEASE; CELL FATE; CELL LABELING; CINEANGIOCARDIOGRAPHY; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; EVIDENCE BASED MEDICINE; HEART FUNCTION; HEART VENTRICLE REMODELING; HUMAN; META ANALYSIS; MOLECULAR IMAGING; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; SYSTOLE; TERATOMA; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANIMALS; CARDIOVASCULAR DISEASES; DIAGNOSTIC IMAGING; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 33746971974     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2006.05.012     Document Type: Article

References (75)

1. Lloyd-Jones D.M., Larson M.G., Leip E.P., Beiser A., D'Agostino R.B., Kannel W.B., et al. Lifetime risk for developing congestive heart failure. the Framingham Heart Study. Circulation 106 (2002) 3068-3072
2. American Heart Association. Heart and stroke statistics-2006 update. American Heart Association Web site. Available from: URL: http://www.americanheart.org/statistics.coronary.html. Accessed April 14, 2006.
3. Anversa P., and Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 83 (1998) 1-14
4. Murry C.E., Wiseman R.W., Schwartz S.M., and Hauschka S.D. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 98 (1996) 2512-2523
5. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
6. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
7. Hodgson D.M., Behfar A., Zingman L.V., Kane G.C., Perez-Terzic C., Alekseev A.E., et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 287 (2004) H471-H479
8. Wollert K.C., and Drexler H. Clinical applications of stem cells for the heart. Circ Res 96 (2005) 151-163
9. Blau H.M., Brazelton T.R., and Weimann J.M. The evolving concept of a stem cell. entity or function?. Cell 105 (2001) 829-841
10. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108 (2001) 407-414
11. Boheler K.R., Czyz J., Tweedie D., Yang H.T., Anisimov S.V., and Wobus A.M. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res 91 (2002) 189-201
12. Wei H., Juhasz O., Li J., Tarasova Y.S., and Boheler K.R. Embryonic stem cells and cardiomyocyte differentiation. phenotypic and molecular analyses. J Cell Mol Med 9 (2005) 804-817
13. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., and Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (2002) 93-98
14. Min J.Y., Yang Y., Sullivan M.F., Ke Q., Converso K.L., Chen Y., et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 125 (2003) 361-369
15. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98 (2001) 10344-10349
16. Silva G.V., Litovsky S., Assad J.A., Sousa A.L., Martin B.J., Vela D., et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111 (2005) 150-156
17. Hamano K., Nishida M., Hirata K., Mikamo A., Li T.S., Harada M., et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease. clinical trial and preliminary results. Jpn Circ J 65 (2001) 845-847
18. Strauer B.E., Brehm M., Zeus T., Kostering M., Hernandez A., Surg R.V., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 (2002) 1913-1918
19. Pagani F.D., DerSimonian H., Zawadzka A., Wetzel K., Edge A.S., Jacoby D.B., et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41 (2003) 879-888
20. Menasche P., Hagege A.A., Vilquin J.T., Desnos M., Abergel E., Pouzet B., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41 (2003) 1078-1083
21. Smits P.C., van Geuns R.J., Poldermans D., Bountioukos M., Onderwater E.E., Lee C.H., et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure. clinical experience with six-month follow-up. J Am Coll Cardiol 42 (2003) 2063-2069
22. Kang H.J., Kim H.S., Zhang S.Y., Park K.W., Cho H.J., Koo B.K., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction. the MAGIC cell randomised clinical trial. Lancet 363 (2004) 751-756
23. Chen S.L., Fang W.W., Ye F., Liu Y.H., Qian J., Shan S.J., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94 (2004) 92-95
24. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction. the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
25. Fernandez-Aviles F., San Roman J.A., Garcia-Frade J., Fernandez M.E., Penarrubia M.J., de la Fuente L., et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 95 (2004) 742-748
26. Perin E.C., Dohmann H.F., Borojevic R., Silva S.A., Sousa A.L., Silva G.V., et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 110 (2004) II213-II218
27. Siminiak T., Kalawski R., Fiszer D., Jerzykowska O., Rzezniczak J., Rozwadowska N., et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury. phase I clinical study with 12 months of follow-up. Am Heart J 148 (2004) 531-537
28. Schachinger V., Assmus B., Britten M.B., Honold J., Lehmann R., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44 (2004) 1690-1699
29. Siminiak T., Fiszer D., Jerzykowska O., Grygielska B., Rozwadowska N., Kalmucki P., et al. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment. the POZNAN trial. Eur Heart J 26 (2005) 1188-1195
30. Katritsis D.G.S.P., Karvouni E., Karabinos I., Korovesis S., Perez S.A., Voridis E.M., et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv 65 (2005) 321-329
31. Ince H., Petzsch M., Kleine H.D., Eckard H., Rehders T., Burska D., et al. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction. final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Circulation 112 (2005) I73-I80
32. Bartunek J., Vanderheyden M., Vandekerckhove B., Mansour S., De Bruyne B., De Bondt P., et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction. feasibility and safety. Circulation 112 (2005) 1178-1183
33. Dib N., Michler R.E., Pagani F.D., Wright S., Kereiakes D.J., Lengerich R., et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy. four-year follow-up. Circulation 112 (2005) 1748-1755
34. Erbs S., Linke A., Adams V., Lenk K., Thiele H., Diederich K.W., et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion. first randomized and placebo-controlled study. Circ Res 97 (2005) 756-762
35. Strauer B.E., Brehm M., Zeus T., Bartsch T., Schannwell C., Antke C., et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease. the IACT Study. J Am Coll Cardiol 46 (2005) 1651-1658
36. Patel A.N., Geffner L., Vina R.F., Saslavsky J., Urschel Jr. H.C., Kormos R., et al. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation. a prospective randomized study. J Thorac Cardiovasc Surg 130 (2005) 1631-1638
37. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction. double-blind, randomised controlled trial. Lancet 367 (2006) 113-121
38. Fuchs S., Kornowski R., Weisz G., Satler L.F., Smits P.C., Okubagzi P., et al. Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. Am J Cardiol 97 (2006) 823-829
39. Meyer G.P., Wollert K.C., Lotz J., Steffens J., Lippolt P., Fichtner S., et al. Intracoronary bone marrow cell transfer after myocardial infarction. eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
40. Zohlnhofer D., Ott I., Mehilli J., Schomig K., Michalk F., Ibrahim T., et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction. a randomized controlled trial. JAMA 295 (2006) 1003-1010
41. Ripa R.S., Jorgensen E., Wang Y., Thune J.J., Nilsson J.C., Sondergaard L., et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction. result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 113 (2006) 1983-1992
42. Jain K.K. Ethical and regulatory aspects of embryonic stem cell research. Expert Opin Biol Ther 5 (2005) 153-162
43. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., and Bongso A. Embryonic stem cell lines from human blastocysts. somatic differentiation in vitro. Nat Biotechnol 18 (2000) 399-404
44. Swijnenburg R.J., Tanaka M., Vogel H., Baker J., Kofidis T., Gunawan F., et al. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112 (2005) I166-I172
45. Drukker M. Immunogenicity of human embryonic stem cells. can we achieve tolerance?. Springer Semin Immunopathol 26 (2004) 201-213
46. Orlic D., Hill J.M., and Arai A.E. Stem cells for myocardial regeneration. Circ Res 91 (2002) 1092-1102
47. Safety study of adult mesenchymal stem cells (MSC) to treat acute myocardial infarction. Available from: URL: http://www.clinicaltrials.gov/ct/show/NCT00114452?order=1
48. Hagege A.A., Carrion C., Menasche P., Vilquin J.T., Duboc D., Marolleau J.P., et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361 (2003) 491-492
49. Menasche P. Myoblast-based cell transplantation. Heart Fail Rev 8 (2003) 221-227
50. Genzyme ends enrollment in phase 2 trial of cardiac cell therapy (2006), Genzyme Corporation, Cambridge [press release]
51. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5 (1999) 434-438
52. Balsam L.B., and Robbins R.C. Haematopoietic stem cells and repair of the ischaemic heart. Clin Sci (Lond) 109 (2005) 483-492
53. Murry C.E., Field L.J., and Menasche P. Cell-based cardiac repair. reflections at the 10-year point. Circulation 112 (2005) 3174-3183
54. Massoud T.F., and Gambhir S.S. Molecular imaging in living subjects. seeing fundamental biological processes in a new light. Genes Dev 17 (2003) 545-580
55. Wu J.C., Tseng J.R., and Gambhir S.S. Molecular imaging of cardiovascular gene products. J Nucl Cardiol 11 (2004) 491-505
56. Barbash I.M., Chouraqui P., Baron J., Feinberg M.S., Etzion S., Tessone A., et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium. feasibility, cell migration, and body distribution. Circulation 108 (2003) 863-868
57. Weissleder R., and Mahmood U. Molecular imaging. Radiology 219 (2001) 316-333
58. Zhou R., Thomas D.H., Qiao H., Bal H.S., Choi S.R., Alavi A., et al. In vivo detection of stem cells grafted in infarcted rat myocardium. J Nucl Med 46 (2005) 816-822
59. Hofmann M., Wollert K.C., Meyer G.P., Menke A., Arseniev L., Hertenstein B., et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111 (2005) 2198-2202
60. Kraitchman D.L., Heldman A.W., Atalar E., Amado L.C., Martin B.J., Pittenger M.F., et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107 (2003) 2290-2293
61. Amado L.C., Saliaris A.P., Schuleri K.H., St John M., Xie J.S., Cattaneo S., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 102 (2005) 11474-11479
62. Arai T., Kofidis T., Bulte J.W., de Bruin J., Venook R.D., Berry G.J., et al. Dual in vivo magnetic resonance evaluation of magnetically labeled mouse embryonic stem cells and cardiac function at 1.5 t. Magn Reson Med 55 (2006) 203-209
63. Kraitchman D.L., Tatsumi M., Gilson W.D., Ishimori T., Kedziorek D., Walczak P., et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 112 (2005) 1451-1461
64. Bulte J.W., and Kraitchman D.L. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17 (2004) 484-499
65. Bengel F.M., Anton M., Avril N., Brill T., Nguyen N., Haubner R., et al. Uptake of radiolabeled 2′-fluoro-2′-deoxy-5-iodo-1-beta-D-arabinofuranosyluracil in cardiac cells after adenoviral transfer of the herpesvirus thymidine kinase gene. the cellular basis for cardiac gene imaging. Circulation 102 (2000) 948-950
66. Wu J.C., Inubushi M., Sundaresan G., Schelbert H., and Gambhir S.S. Optical imaging of cardiac reporter gene expression in living rats. Circulation 105 (2002) 1631-1634
67. Wu J.C., Inubushi M., Sundaresan G., Schelbert H.R., and Gambhir S.S. Positron emission tomography imaging of cardiac reporter gene expression in living rats. Circulation 106 (2002) 180-183
68. Inubushi M., Wu J.C., Gambhir S.S., Sundaresan G., Satyamurthy N., Namavari M., et al. Positron-emission tomography reporter gene expression imaging in rat myocardium. Circulation 107 (2003) 326-332
69. Chen I.Y., Wu J.C., Min J.J., Sundaresan G., Lewis X., Liang Q., et al. Micro-positron emission tomography imaging of cardiac gene expression in rats using bicistronic adenoviral vector-mediated gene delivery. Circulation 109 (2004) 1415-1420
70. Wu J.C., Chen I.Y., Sundaresan G., Min J.J., De A., Qiao J.H., et al. Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation 108 (2003) 1302-1305
71. Cao F., Lin S., Xie X., Ray P., Patel M., Zhang X., et al. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113 (2006) 1005-1014
72. Wu J.C., Spin J.M., Cao F., Lin S., Xie X., Gheysens O., et al. Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation. Physiol Genomics 25 (2006) 29-38
73. Gao X., Yang L., Petros J.A., Marshall F.F., Simons J.W., and Nie S. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 16 (2005) 63-72
74. Murasawa S., Kawamoto A., Horii M., Nakamori S., and Asahara T. Niche-dependent translineage commitment of endothelial progenitor cells, not cell fusion in general, into myocardial lineage cells. Arterioscler Thromb Vasc Biol 25 (2005) 1388-1394
75. So M.K., Xu C., Loening A.M., Gambhir S.S., and Rao J. Self-illuminating quantum dot conjugates for in vivo imaging. Nat Biotechnol 24 (2006) 339-343